Autoinjectors Market

Autoinjectors Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

230

Base Year:

2023

Sep - 2024

Format:

Report Code:

VMR-2474

Segments Covered

By Usage Disposable Autoinjectors, Reusable Autoinjectors
By Technology Manual Autoinjectors, Automatic Autoinjectors
By Route of Administration Subcutaneous, Intramuscular
By Therapy Diabetes, Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Other Therapy Areas
By Region North America, Aisa Pacific, Europe, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 0.97 Billion
Revenue 2032:	USD 3.27 Billion
Revenue CAGR (2024 - 2032):	14.5%
Fastest Growing Region (2024 - 2032)	Aisa Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Autoinjectors Market - Segment Analysis
1. Overview
2. Global Autoinjectors Market, 2016 - 2028 (USD Million)
3. Global Autoinjectors Market - by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. Global Autoinjectors Market - by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. Global Autoinjectors Market - by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. Global Autoinjectors Market - by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. Global Autoinjectors Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Autoinjectors Market - Segment Analysis
1. Overview
2. North America Autoinjectors Market, 2016 - 2028 (USD Million)
3. North America Autoinjectors Market, by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. North America Autoinjectors Market, by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. North America Autoinjectors Market, by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. North America Autoinjectors Market, by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. North America Autoinjectors Market, by Country
  1. U.S.
    1. U.S. Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. U.S. Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. U.S. Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. U.S. Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  2. Canada
    1. Canada Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Canada Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Canada Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Canada Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  3. Mexico
    1. Mexico Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Mexico Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Mexico Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Mexico Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
Europe Autoinjectors Market - Segment Analysis
1. Overview
2. Europe Autoinjectors Market, 2016 - 2028 (USD Million)
3. Europe Autoinjectors Market, by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. Europe Autoinjectors Market, by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. Europe Autoinjectors Market, by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. Europe Autoinjectors Market, by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. Europe Autoinjectors Market, by Country
  1. Germany
    1. Germany Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Germany Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Germany Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Germany Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  2. UK
    1. UK Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. UK Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. UK Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. UK Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  3. France
    1. France Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. France Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. France Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. France Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  4. Spain
    1. Spain Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Spain Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Spain Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Spain Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  5. Italy
    1. Italy Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Italy Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Italy Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Italy Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  6. BENELUX
    1. BENELUX Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. BENELUX Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. BENELUX Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. BENELUX Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  7. Rest of Europe
    1. Rest Of Europe Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Rest Of Europe Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Rest Of Europe Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Rest Of Europe Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
Asia Pacific Autoinjectors Market - Segment Analysis
1. Overview
2. Asia Pacific Autoinjectors Market, 2016 - 2028 (USD Million)
3. Asia Pacific Autoinjectors Market, by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. Asia Pacific Autoinjectors Market, by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. Asia Pacific Autoinjectors Market, by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. Asia Pacific Autoinjectors Market, by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. Asia Pacific Autoinjectors Market, by Country
  1. China
    1. China Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. China Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. China Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. China Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  2. Japan
    1. Japan Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Japan Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Japan Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Japan Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  3. India
    1. India Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. India Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. India Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. India Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  4. South Korea
    1. South Korea Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. South Korea Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. South Korea Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. South Korea Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  5. South East Asia
    1. South East Asia Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. South East Asia Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. South East Asia Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. South East Asia Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Rest of Asia Pacific Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Rest of Asia Pacific Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Rest of Asia Pacific Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
Latin America Autoinjectors Market - Segment Analysis
1. Overview
2. Latin America Autoinjectors Market, 2016 - 2028 (USD Million)
3. Latin America Autoinjectors Market, by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. Latin America Autoinjectors Market, by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. Latin America Autoinjectors Market, by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. Latin America Autoinjectors Market, by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. Latin America Autoinjectors Market, by Country
  1. Brazil
    1. Brazil Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Brazil Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Brazil Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Brazil Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  2. Argentina
    1. Argentina Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Argentina Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Argentina Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Argentina Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  3. Rest of Latin America
    1. Rest of Latin America Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Rest of Latin America Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Rest of Latin America Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Rest of Latin America Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
Middle East & Africa Autoinjectors Market - Segment Analysis
1. Overview
2. Middle East & Africa Autoinjectors Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Autoinjectors Market, by Usage
  1. By Disposable Autoinjectors
  2. By Reusable Autoinjectors
4. Middle East & Africa Autoinjectors Market, by Technology
  1. By Manual Autoinjectors
  2. By Automatic Autoinjectors
5. Middle East & Africa Autoinjectors Market, by Route of Administration
  1. By Subcutaneous
  2. By Intramuscular
6. Middle East & Africa Autoinjectors Market, by Therapy
  1. By Diabetes
  2. By Rheumatoid Arthritis
  3. By Multiple Sclerosis
  4. By Anaphylaxis
  5. By Other Therapy Areas
7. Middle East & Africa Autoinjectors Market, by Country
  1. GCC Countries
    1. GCC Countries Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. GCC Countries Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. GCC Countries Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. GCC Countries Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  2. South Africa
    1. South Africa Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. South Africa Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. South Africa Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. South Africa Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Autoinjectors Market, By Usage
      1. By Disposable Autoinjectors
      2. By Reusable Autoinjectors
    2. Rest of Middle East & Africa Autoinjectors Market, By Technology
      1. By Manual Autoinjectors
      2. By Automatic Autoinjectors
    3. Rest of Middle East & Africa Autoinjectors Market, By Route of Administration
      1. By Subcutaneous
      2. By Intramuscular
    4. Rest of Middle East & Africa Autoinjectors Market, By Therapy
      1. By Diabetes
      2. By Rheumatoid Arthritis
      3. By Multiple Sclerosis
      4. By Anaphylaxis
      5. By Other Therapy Areas
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Becton Dickinson and Company (U.S.)
2. SHL Medical (Switzerland)
3. Ypsomed Holding AG (Switzerland)
4. Owen Mumford (UK)
5. Teva Pharmaceuticals USA Inc. (U.S.)
6. Phillips-Medisize Corp. (U.S.)
7. Jabil Inc. (U.S.)
8. Haselmeier (Germany)
9. Gerresheimer AG (Germany)
10. E3D Elcam Drug Delivery Devices (Israel)
11. Oval Medical Technologies Ltd. (UK)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 16-May-2024

FUJIFILM and SHL Medical Partner to Expand Auto Injector Production

FAQ

Frequently Asked Question

What is the global demand for Autoinjectors in terms of revenue?

The global Autoinjectors valued at USD 0.97 Billion in 2023 and is expected to reach USD 3.27 Billion in 2032 growing at a CAGR of 14.5%.

Which are the prominent players in the market?

The prominent players in the market are Becton Dickinson and Company (U.S.), SHL Medical (Switzerland), Ypsomed Holding AG (Switzerland), Owen Mumford (UK), Teva Pharmaceuticals USA Inc. (U.S.), Phillips-Medisize Corp. (U.S.), Jabil Inc. (U.S.), Haselmeier (Germany), Gerresheimer AG (Germany), E3D Elcam Drug Delivery Devices (Israel), Oval Medical Technologies Ltd. (UK).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 14.5% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Autoinjectors include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Autoinjectors in 2023.

Autoinjectors Market

Autoinjectors Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Autoinjectors in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Autoinjectors Market

Autoinjectors Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Autoinjectors in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Autoinjectors Market

Vantage Point Interactive Dashboard